Prolactin levels during long-term risperidone treatment in children and adolescents: A reanalysis of data

Abstract

To summarize, the results of our reanalysis support our statements in the manuscript. Of particular note, our finding that there was no direct correlation between prolactin elevation and SHAP is supported by the data in the reanalysis. In addition, our Conclusion section remains accurate.